High Throughput Screening Identifies Novel Lead Compounds with Activity against Larval, Juvenile and Adult Schistosoma mansoni

被引:34
作者
Mansour, Nuha R. [1 ]
Paveley, Ross [1 ]
Gardner, J. Mark F. [2 ]
Bell, Andrew S. [2 ]
Parkinson, Tanya [2 ]
Bickle, Quentin [1 ]
机构
[1] London Sch Hyg & Trop Med, Dept Infect Immunol, London WC1, England
[2] Salvensis, Discovery Pk House,Discovery Pk, Sandwich, Kent, England
基金
英国医学研究理事会;
关键词
DRUG DISCOVERY; PRAZIQUANTEL; ASSAY; STRATEGIES; INHIBITORS; LIBRARY; HIT;
D O I
10.1371/journal.pntd.0004659
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
An estimated 600 million people are affected by the helminth disease schistosomiasis caused by parasites of the genus Schistosoma. There is currently only one drug recommended for treating schistosomiasis, praziquantel (PZQ), which is effective against adult worms but not against the juvenile stage. In an attempt to identify improved drugs for treating the disease, we have carried out high throughput screening of a number of small molecule libraries with the aim of identifying lead compounds with balanced activity against all life stages of Schistosoma. A total of almost 300,000 compounds were screened using a high throughput assay based on motility of worm larvae and image analysis of assay plates. Hits were screened against juvenile and adult worms to identify broadly active compounds and against a mammalian cell line to assess cytotoxicity. A number of compounds were identified as promising leads for further chemical optimization.
引用
收藏
页数:12
相关论文
共 25 条
[1]   Drug Discovery for Schistosomiasis: Hit and Lead Compounds Identified in a Library of Known Drugs by Medium-Throughput Phenotypic Screening [J].
Abdulla, Maha-Hamadien ;
Ruelas, Debbie S. ;
Wolff, Brian ;
Snedecor, June ;
Lim, Kee-Chong ;
Xu, Fengyun ;
Renslo, Adam R. ;
Williams, Janice ;
McKerrow, James H. ;
Caffrey, Conor R. .
PLOS NEGLECTED TROPICAL DISEASES, 2009, 3 (07)
[2]   PRAZIQUANTEL [J].
ANDREWS, P ;
THOMAS, H ;
POHLKE, R ;
SEUBERT, J .
MEDICINAL RESEARCH REVIEWS, 1983, 3 (02) :147-200
[3]   Screening and hit evaluation of a chemical library against blood-stage Plasmodium falciparum [J].
Avery, Vicky M. ;
Bashyam, Sridevi ;
Burrows, Jeremy N. ;
Duffy, Sandra ;
Papadatos, George ;
Puthukkuti, Shyni ;
Sambandan, Yuvaraj ;
Singh, Shivendra ;
Spangenberg, Thomas ;
Waterson, David ;
Willis, Paul .
MALARIA JOURNAL, 2014, 13
[4]  
BENSON AB, 1993, J CELL BIOCHEM, P278
[5]   Praziquantel [J].
Cioli, D ;
Pica-Mattoccia, L .
PARASITOLOGY RESEARCH, 2003, 90 (Suppl 1) :S3-S9
[6]   Comparison of a High-Throughput High-Content Intracellular Leishmania donovani Assay with an Axenic Amastigote Assay [J].
De Rycker, Manu ;
Hallyburton, Irene ;
Thomas, John ;
Campbell, Lorna ;
Wyllie, Susan ;
Joshi, Dhananjay ;
Cameron, Scott ;
Gilbert, Ian H. ;
Wyatt, Paul G. ;
Frearson, Julie A. ;
Fairlamb, Alan H. ;
Gray, David W. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (07) :2913-2922
[7]   Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs [J].
Doenhoff, M. J. ;
Hagan, P. ;
Cioli, D. ;
Southgate, V. ;
Pica-Mattoccia, L. ;
Botros, S. ;
Coles, G. ;
Tchuente, L. A. Tchuem ;
Mbaye, A. ;
Engels, D. .
PARASITOLOGY, 2009, 136 (13) :1825-1835
[8]   Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis [J].
Doenhoff, Michael J. ;
Cioli, Donato ;
Utzinger, Juerg .
CURRENT OPINION IN INFECTIOUS DISEASES, 2008, 21 (06) :659-667
[9]  
ELIGAIL AB, 1985, J TROP MED HYG, V88, P101
[10]   The Schistosomiasis Control Initiative (SCI): rationale, development and implementation from 2002-2008 [J].
Fenwick, A. ;
Webster, J. P. ;
Bosque-Oliva, E. ;
Blair, L. ;
Fleming, F. M. ;
Zhang, Y. ;
Garba, A. ;
Stothard, J. R. ;
Gabrielli, A. F. ;
Clements, A. C. A. ;
Kabatereine, N. B. ;
Toure, S. ;
Dembele, R. ;
Nyandindi, U. ;
Mwansa, J. ;
Koukounari, A. .
PARASITOLOGY, 2009, 136 (13) :1719-1730